Physician profile
Edward Chau
NPI 1821529587
$8,598.90
in general payments reported to CMS, 2019-2025
28 companies · $2,303 in 2025
The $2,303 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.23 · 2020: $61.47 · 2021: $484 · 2022: $1,316 · 2023: $1,923 · 2024: $2,492 · 2025: $2,303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,347 · Travel and Lodging: $1,176 · Grant: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,347.45 |
| Travel and Lodging | $1,175.76 |
| Grant | $195.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,737.97 | 2023-2025 | Mitraclip, Triclip, Dragonfly Opstar |
| Biotronik INC. | $1,635.25 | 2021-2024 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Nhancer Rx |
| Shockwave Medical, INC | $1,479.32 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $694.04 | 2023-2025 | Intracardiac Undivided, Igt Devices Undivided, (Ck4) Mcot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $619.39 | 2021-2024 | Lifevest |
| Boston Scientific Corporation | $512.29 | 2024-2025 | Watchman Flx, Watchman, General - Structural Heart |
| Edwards Lifesciences Corporation | $238.24 | 2025 | Sapien 3 Ultra Resilia |
| Amgen INC. | $237.49 | 2022-2023 | Repatha |
| Kestra Medical Technology Services, INC. | $182.10 | 2025 | Assure Wcd |
| Madrigal Pharmaceuticals | $150.00 | 2025 | Rezdiffra |
| Asahi Intecc USA, INC. | $146.16 | 2025 | Asahi Coronary Wires |
| Janssen Pharmaceuticals, INC | $136.76 | 2021-2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $122.31 | 2023 | Arcalyst |
| Medtronic, INC. | $114.09 | 2025 | Linq II |
| Novartis Pharmaceuticals Corporation | $107.88 | 2020-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $107.80 | 2022-2024 | Camzyos |
| Abiomed | $47.81 | 2023 | Impella |
| Pfizer INC. | $45.60 | 2019-2020 | |
| Lantheus Medical Imaging, INC. | $41.31 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $40.15 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $39.21 | 2024-2025 | Wainua, Farxiga |
| Heartflow, INC. | $31.02 | 2022 | |
| Novo Nordisk INC | $29.14 | 2024 | Rybelsus, Ozempic |
| Cvrx, INC. | $25.52 | 2025 | Barostim Neo System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.50 | 2025 | Jardiance |
| Regeneron Healthcare Solutions, INC. | $21.13 | 2025 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $17.23 | 2025 | |
| Cathworks, INC. | $15.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Chau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.